IDEA CELLULAR share price has plunged 6% and is presently trading at Rs 58.
Meanwhile, the BSE 500 Index is at 14,890 (Up 0.2%).
Among the top losers in the BSE 500 Index today are IDEA CELLULAR (down 5.74%) and BHARTI AIRTEL (down 5.39%)
PC JEWELLER (up 7.25%) and MPHASIS LTD (up 5.84%) are among the top gainers today.
Over the last one year, IDEA CELLULAR has moved down from Rs 91 to Rs 58, registering a loss of Rs 33 (down 39.26%).
The BSE 500 has moved up from 13,151 to 14,890, registering a gain of 1,739 points (up 13.02%) during the last 12 months.
The top gainers among the BSE 500 Index stocks during this same period were HEG LTD (up 947.35%), GRAPHITE INDIA (up 534.46%) and INDIABULLS VENTURES (up 269.98%).
What About the Benchmark Indices?
The BSE Sensex is at 35,389 (up 0.20%). The top gainers among the BSE Sensex stocks today are ASIAN PAINTS (up 4.73%), L&T (up 0.80%) and DR. REDDYS LAB (up 0.80%). Other gainers include KOTAK MAH. BANK (up 0.75%) and COAL INDIA (up 0.67%). The most traded stocks in the BSE Sensex are ASIAN PAINTS and ICICI BANK.
In the meantime, NSE Nifty is at 10,762 (up 0.19%). ASIAN PAINTS (up 4.79%) and HPCL (up 2.14%) are among the top gainers in NSE Nifty.
Over the last 12 months, the BSE Sensex has moved up from 30,248 to 35,389, registering a gain of 5,141 points (up 16.76%).
IDEA CELLULAR Financial Update...
IDEA CELLULAR net profit grew 80.7% YoY to Rs 10 billion for the quarter ended March 2018, compared to a profit of Rs 13 billion a year ago. Net Sales rose 94.3% to Rs 61.4 billion during the period as against Rs 65.1 billion in January-March 2017.
For the year ended March 2017, IDEA CELLULAR reported 35.6% decrease in net profit to Rs 8.2 billion compared to net profit of Rs 23.1 billion during FY16.
Revenue of the company grew 99.0% to Rs 356 billion during FY17.
The current Price to earnings ratio of IDEA CELLULAR, based on rolling 12 month earnings, stands at 84.9x.
This article was originally published in English at www.equitymaster.com
Read the complete Indian stock market update. For the terms of use, go here.
No comments:
Post a Comment